BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26341563)

  • 1. Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination.
    Fenoll A; Granizo JJ; Giménez MJ; Yuste J; Aguilar L
    Vaccine; 2015 Oct; 33(42):5691-5699. PubMed ID: 26341563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines.
    del Amo E; Brotons P; Monsonis M; Triviño M; Iñigo M; Selva L; Sa-Leão R; Muñoz-Almagro C
    Clin Microbiol Infect; 2014 Jul; 20(7):684-9. PubMed ID: 24467648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCV13 serotype decrease in Italian adolescents and adults in the post-PCV13 era: Herd protection from children or secular trend?
    Nieddu F; Moriondo M; De Vitis E; Ricci S; Indolfi G; Resti M; Vocale C; Landini MP; Sartor A; Azzari C;
    Vaccine; 2017 Mar; 35(11):1544-1550. PubMed ID: 28190742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
    van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
    PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines.
    Koutouzis EI; Michos A; Koutouzi FI; Chatzichristou P; Parpounas K; Georgaki A; Theodoridou M; Tsakris A; Syriopoulou VP
    Pediatr Infect Dis J; 2016 Mar; 35(3):292-6. PubMed ID: 26569193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009.
    Fenoll A; Aguilar L; Vicioso MD; Gimenez MJ; Robledo O; Granizo JJ
    BMC Infect Dis; 2011 Sep; 11():239. PubMed ID: 21910891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
    J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.
    Lo SW; Gladstone RA; van Tonder AJ; Lees JA; du Plessis M; Benisty R; Givon-Lavi N; Hawkins PA; Cornick JE; Kwambana-Adams B; Law PY; Ho PL; Antonio M; Everett DB; Dagan R; von Gottberg A; Klugman KP; McGee L; Breiman RF; Bentley SD;
    Lancet Infect Dis; 2019 Jul; 19(7):759-769. PubMed ID: 31196809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
    Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
    Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case-control study.
    Guevara M; Barricarte A; Torroba L; Herranz M; Gil-Setas A; Gil F; Bernaola E; Ezpeleta C; Castilla J;
    Euro Surveill; 2016; 21(14):. PubMed ID: 27103428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.
    Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C;
    Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.
    van der Linden M; Perniciaro S; Imöhl M
    BMC Infect Dis; 2015 May; 15():207. PubMed ID: 25940580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era.
    de Miguel S; Domenech M; González-Camacho F; Sempere J; Vicioso D; Sanz JC; Comas LG; Ardanuy C; Fenoll A; Yuste J
    Clin Infect Dis; 2021 Dec; 73(11):e3778-e3787. PubMed ID: 32990303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W; Srifeungfung S; Chatsuwan T; Nunthapisud P; Treerauthaweeraphong V; Rungnobhakhun P; Sricharoenchai S; Chokephaibulkit K
    Hum Vaccin Immunother; 2014; 10(7):1866-73. PubMed ID: 25424794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.